Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.676
-0.017 (-2.52%)
At close: Feb 21, 2025, 4:00 PM
0.700
+0.024 (3.54%)
After-hours: Feb 21, 2025, 7:58 PM EST
Lineage Cell Therapeutics Employees
As of December 31, 2023, Lineage Cell Therapeutics had 75 total employees, including 68 full-time and 7 part-time employees. The number of employees decreased by 3 or -3.85% compared to the previous year.
Employees
75
Change (1Y)
-3
Growth (1Y)
-3.85%
Revenue / Employee
$116,253
Profits / Employee
-$268,147
Market Cap
154.34M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
LCTX News
- 11 days ago - Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury - Business Wire
- 18 days ago - Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences Conference - Business Wire
- 25 days ago - Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering - Business Wire
- 6 weeks ago - Lineage Cell Therapeutics Issues Letter to Stockholders - Business Wire
- 3 months ago - Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering - Business Wire
- 3 months ago - Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering - Business Wire
- 3 months ago - Lineage Cell Therapeutics, Inc. (LCTX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire